Cancer Risk Prediction and Assessment


Overview

Accurately assessing cancer risk in average- and high-risk individuals and determining cancer prognosis in patients are crucial to controlling the suffering and death due to cancer. Cancer prediction models provide an important approach to assessing risk and prognosis by identifying individuals at high risk, facilitating the design and planning of clinical cancer trials, fostering the development of benefit-risk indices, and enabling estimates of the population burden and cost of cancer. Models also may aid in the evaluation of treatments and interventions.

[Return to Top]


Risk Prediction Models

The following risk prediction models are grouped by cancer site and whether their methodology and results have been peer-reviewed.

Risk Prediction Models in Peer-Reviewed Scientific Journals

Other Online Risk Prediction Models

Note: NCI and EGRP are not responsible for the content of external Web sites. Read our disclaimer for more information.

[Return to Top]


Other Research Resources

[Return to Top]


Funded Projects

View a list of active cancer risk prediction and assessment grants supported by the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population SciencesExternal Web Site Policy.

[Return to Top]


Funding Opportunities

NCI-sponsored Funding Opportunity Announcements related to cancer risk prediction and assessment include:

EGRP joins with other NCI Divisions, Offices, and Centers and other Institutes and Centers at the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs. View the full list of EGRP FOAs.

EGRP also encourages investigator-initiated grant applications on cancer risk prediction and assessment topics.

[Return to Top]


Public Resources

[Return to Top]


Key Publications

[Return to Top]


Workshops

[Return to Top]


Contacts

For general questions about cancer risk prediction models and assessment, EGRP contacts include:

[Return to Top]

Last Updated: 16 Apr 2012

Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov